California Plasma Coalition (CalPlasma) is working to address barriers to source plasma donations and help save more lives.

“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

Richard Geary; Executive Vice President, Chief Development Officer; Ionis Pharmaceuticals Inc Elizabeth Hougen; Chief Financial Officer, Executive Vice President - Finance; Ionis Pharmaceuticals Inc ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

Bristol Myers Squibb today announced new five-year results from the POETYK PSO long-term extension (LTE) trial of Sotyktu (deucravacitinib) treatment in adult patients with moderate-to-severe plaque ...

The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

A series of injectable and oral treatments that require chronic dosing are already available ... but frequently do not eliminate all, angioedema attacks and require lifelong administration.

Ionis Pharmaceuticals IONS incurred a loss of 66 cents per share for fourth-quarter 2024, which was narrower than the Zacks ...

In a recent conference call to discuss its 2024 Q4 financial results, Ionis Pharmaceuticals highlighted its transition into a ...

Angioedema, whether histamine- or bradykinin-mediated ... diagnosed via endoscopy when other causes are ruled out. Chronic obstructive lung diseases, including asthma, chronic bronchitis, and ...